General Information of Disease (ID: DISI3721)

Disease Name MASS syndrome
Synonyms overlap connective tissue disease; OCTD; Mitral valve prolapse, Aortic enlargement, Skin and Skeletal findings; MASS phenotype; MASS syndrome
Definition
A genetic disorder of connective tissue caused by mutations in the FBN1 gene. Connective tissue is the material between the cells of the body that gives tissues form and strength. Symptoms include mitral valve prolapse, nearsightedness, borderline and non-progressive aortic enlargement, and skin and skeletal findings that overlap with those seen in Marfan syndrome. Treatment is based on the individuals symptoms.
Disease Hierarchy
DISSDDNA: Overlapping connective tissue disease
DIS8I9FS: Hereditary disorder of connective tissue
DISI3721: MASS syndrome
Disease Identifiers
MONDO ID
MONDO_0011431
MESH ID
C536030
UMLS CUI
C1858556
OMIM ID
604308
MedGen ID
346932
Orphanet ID
99715

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 5 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
ARSB TTESQTG Limited Biomarker [1]
LRP5 TT7VMG4 Limited Biomarker [2]
DKK1 TTE3RAC Strong Biomarker [3]
S1PR3 TTDYP7I Strong Altered Expression [4]
SOST TTYRO4F Strong Biomarker [5]
------------------------------------------------------------------------------------
This Disease Is Related to 7 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
ANKH OTCN25R5 Strong Genetic Variation [6]
FERMT2 OTZNPWWX Strong Biomarker [7]
NEGR1 OT57ECW9 Strong Biomarker [8]
SLIT3 OTU8MKEU Strong Genetic Variation [9]
SMURF1 OT5UIZR8 Strong Biomarker [10]
SMURF2 OT3TRVL7 Strong Biomarker [10]
FBN1 OTYCJT63 Definitive Autosomal dominant [11]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 DOT(s)

References

1 The Lysosomal Protein Arylsulfatase B Is a Key Enzyme Involved in Skeletal Turnover.J Bone Miner Res. 2018 Dec;33(12):2186-2201. doi: 10.1002/jbmr.3563. Epub 2018 Aug 24.
2 The high bone mass phenotype of Lrp5-mutant mice is not affected by megakaryocyte depletion.Biochem Biophys Res Commun. 2018 Mar 4;497(2):659-666. doi: 10.1016/j.bbrc.2018.02.127. Epub 2018 Feb 15.
3 Increased anabolic bone response in Dkk1 KO mice following tibial compressive loading.Bone. 2020 Feb;131:115054. doi: 10.1016/j.bone.2019.115054. Epub 2019 Sep 12.
4 Deficiency of sphingosine-1-phosphate receptor 3 does not affect the skeletal phenotype of mice lacking sphingosine-1-phosphate lyase.PLoS One. 2019 Jul 17;14(7):e0219734. doi: 10.1371/journal.pone.0219734. eCollection 2019.
5 Lrp4 expression by adipocytes and osteoblasts differentially impacts sclerostin's endocrine effects on body composition and glucose metabolism.J Biol Chem. 2019 Apr 26;294(17):6899-6911. doi: 10.1074/jbc.RA118.006769. Epub 2019 Mar 6.
6 A Phe377del mutation in ANK leads to impaired osteoblastogenesis and osteoclastogenesis in a mouse model for craniometaphyseal dysplasia (CMD).Hum Mol Genet. 2011 Mar 1;20(5):948-61. doi: 10.1093/hmg/ddq541. Epub 2010 Dec 13.
7 Lipoatrophy and metabolic disturbance in mice with adipose-specific deletion of kindlin-2.JCI Insight. 2019 Jul 11;4(13):e128405. doi: 10.1172/jci.insight.128405. eCollection 2019 Jul 11.
8 Functional inactivation of the genome-wide association study obesity gene neuronal growth regulator 1 in mice causes a body mass phenotype.PLoS One. 2012;7(7):e41537. doi: 10.1371/journal.pone.0041537. Epub 2012 Jul 23.
9 Targeting skeletal endothelium to ameliorate bone loss.Nat Med. 2018 Jun;24(6):823-833. doi: 10.1038/s41591-018-0020-z. Epub 2018 May 21.
10 SMURF2 regulates bone homeostasis by disrupting SMAD3 interaction with vitamin D receptor in osteoblasts.Nat Commun. 2017 Feb 20;8:14570. doi: 10.1038/ncomms14570.
11 Four novel FBN1 mutations: significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome. Genomics. 1993 Aug;17(2):468-75. doi: 10.1006/geno.1993.1349.